Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javid Moslehi

Showing results (51-60 of 148) with videos related to

Pageof 15
Sort By:
Journal of Chemical Information and Modeling|May 2, 2018
In Silico Pharmacoepidemiologic Evaluation of Drug-Induced Cardiovascular Complications Using Combined ClassifiersChuipu Cai, Jiansong Fang, Pengfei Guo, et al.
Critical Reviews in Oncology/Hematology|December 9, 2015
Cardiovascular disease following hematopoietic stem cell transplantation: Pathogenesis, detection, and the cardioprotective role of aerobic trainingJessica M Scott, Saro Armenian, Sergio Giralt, et al.
The American Journal of Cardiology|August 30, 2008
Hepatocellular carcinoma with intracavitary cardiac involvement: a case report and review of the literatureAnthony D Sung, Susan Cheng, Javid Moslehi, et al.
Blood|December 22, 2007
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failureYoji Andrew Minamishima, Javid Moslehi, Nabeel Bardeesy, et al.
Circulation|March 2, 2016
Cardiovascular Complications of Novel Multiple Myeloma TreatmentsWeijuan Li, R Frank Cornell, Daniel Lenihan, et al.
Physiological Reviews|September 22, 2025
Forward and reverse cardio-oncologyWouter C Meijers, Joseph Pierre Aboumsallem, Alexander R Lyon, et al.
Circulation|December 3, 2014
ABCDE steps to prevent heart disease in breast cancer survivorsKamaneh Montazeri, Christine Unitt, JoAnne M Foody, et al.
Molecular and Cellular Biology|February 28, 2002
Diverse effects of mutations in exon II of the von Hippel-Lindau (VHL) tumor suppressor gene on the interaction of pVHL with the cytosolic chaperonin and pVHL-dependent ubiquitin ligase activityWilliam J Hansen, Michael Ohh, Javid Moslehi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 27, 2019
Tyrosine Kinase Inhibitors in Leukemia and Cardiovascular Events: From Mechanism to Patient CareAli Manouchehri, Elishama Kanu, Michael J Mauro, et al.
Journal of the American College of Cardiology|September 5, 2015
Vascular and Metabolic Implications of Novel Targeted Cancer Therapies: Focus on Kinase InhibitorsWeijuan Li, Kevin Croce, David P Steensma, et al.
Pageof 15

Showing results (51-60 of 148) with videos related to

Sort By:
Pageof 15
Journal of Chemical Information and Modeling|May 2, 2018
In Silico Pharmacoepidemiologic Evaluation of Drug-Induced Cardiovascular Complications Using Combined ClassifiersChuipu Cai, Jiansong Fang, Pengfei Guo, et al.
Critical Reviews in Oncology/Hematology|December 9, 2015
Cardiovascular disease following hematopoietic stem cell transplantation: Pathogenesis, detection, and the cardioprotective role of aerobic trainingJessica M Scott, Saro Armenian, Sergio Giralt, et al.
The American Journal of Cardiology|August 30, 2008
Hepatocellular carcinoma with intracavitary cardiac involvement: a case report and review of the literatureAnthony D Sung, Susan Cheng, Javid Moslehi, et al.
Blood|December 22, 2007
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failureYoji Andrew Minamishima, Javid Moslehi, Nabeel Bardeesy, et al.
Circulation|March 2, 2016
Cardiovascular Complications of Novel Multiple Myeloma TreatmentsWeijuan Li, R Frank Cornell, Daniel Lenihan, et al.
Physiological Reviews|September 22, 2025
Forward and reverse cardio-oncologyWouter C Meijers, Joseph Pierre Aboumsallem, Alexander R Lyon, et al.
Circulation|December 3, 2014
ABCDE steps to prevent heart disease in breast cancer survivorsKamaneh Montazeri, Christine Unitt, JoAnne M Foody, et al.
Molecular and Cellular Biology|February 28, 2002
Diverse effects of mutations in exon II of the von Hippel-Lindau (VHL) tumor suppressor gene on the interaction of pVHL with the cytosolic chaperonin and pVHL-dependent ubiquitin ligase activityWilliam J Hansen, Michael Ohh, Javid Moslehi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 27, 2019
Tyrosine Kinase Inhibitors in Leukemia and Cardiovascular Events: From Mechanism to Patient CareAli Manouchehri, Elishama Kanu, Michael J Mauro, et al.
Journal of the American College of Cardiology|September 5, 2015
Vascular and Metabolic Implications of Novel Targeted Cancer Therapies: Focus on Kinase InhibitorsWeijuan Li, Kevin Croce, David P Steensma, et al.
Pageof 15